Prodynorphin mRNA expression is increased in the patch vs matrix compartment of the caudate nucleus in suicide subjects

Molecular Psychiatry

Volumn 2, Issue 6, 1997, Pages 495-500

  Hurd, Y L ^a,c   Herman, M M ^b   Hyde, T M ^b   Bigelow, L B ^b   Weinberger, D R ^b   Kleinman, J E ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Depression; Dopamine receptors; Enkephalin; Human; In situ hybridization; Limbic; Opioid neuropeptides; Striatum

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; MESSENGER RNA; NEUROPEPTIDE; OPIATE; OPIATE PEPTIDE; PRODYNORPHIN; ENDORPHIN;

ADULT; AGED; ARTICLE; AUTOPSY; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SUICIDE; BRAIN REGION; BRAIN TISSUE; GENETIC TRANSCRIPTION; IN SITU HYBRIDIZATION; PROTEIN EXPRESSION; RISK FACTOR; SCHIZOPHRENIA;

EID: 0031413938     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000319     Document Type: Article

References (29)

1. Lindstrom LH, Widerlov E, Gunne LM, Wahlstrom A, Terenius L. Endorphins in human cerebrospinal fluid: clinical correlations to some psychotic states. Acta Psychiatr Scand 1978; 57: 153-164.
2. Naber D, Pickar D, Post RM, Van Kammen DP, Waters RN, Ballenger JC et al. Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers. Am J Psychiatry 1981; 138: 1457-1462.
3. Lindstrom LH, Besev G, Gunne LM, Terenius L. CSF levels of receptor-active endorphins in schizophrenic patients: correlations with symptomatology and monoamine metabolites. Psychiatr Res 1986; 19: 93-100.
4. Kleinman JE, Hong J, Iadarola M, Govoni S, Gillin CJ. Neuropeptides in human brain - postmortem studies. Prog Neuro-Psychopharmacol Biol Psych 1985; 9: 91-95.
5. Toru M, Watanabe S, Shibuya H, Nishikawa T, Noda K, Mitsushio H et al. Neurotransmitters, receptors and nouropeptides in postmortem brains of chronic schizophrenic patients. Acta Psychiatr Scand 1988; 78: 121-137.
6. Gerfen CR. The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Ann Rev Neurosci 1992; 15: 285-320.
7. Jaskiw G, Weinberger D. Dopamine and schizophrenia - a cortically corrective perspective. Sem Neurosci 1992; 4: 179-188.
8. Graybiel AM. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 1990; 13: 244-254.
9. Hurd YL, Herkenham M. Neuropeptide compartmentalization within the human neostriatum: in situ hybridization and in vitro autoradiography characterization. Neuroscience 1995; 64: 571-586.
10. Hurd YL. Differential messenger RNA expression of prodynorphin and proenkophalin in the human brain. Neuroscience 1996; 72: 767-783.
11. Mengod G, Vilaro MT, Niznik HB, Sunahara RK, Seeman P, O'Dowd BF et al. Visualization of a dopamine D1 receptor mRNA in human and rat brain. Molec Brain Res 1991; 10: 185-191.
12. Hurd YL, Herkenham M. Molecular alterations in the neostriatum of human cocaine addicts. Synapse 1993; 13: 357-369.
13. Knable MB, Hyde TM, Herman MM, Carter JM, Bigelow L, Kleinman JE. Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients. Biol Psychiatr 1994; 36: 827-835.
14. 11C]raclopride. Arch Gen Psychiat 1990; 47: 213-219.
15. Harrington KA, Augood SJ, Faull RLM, McKenna PJ, Emson PC. Dopamine D1 receptor, D2 receptor, proenkephalin A and substance P gene expression in the caudate nucleus of control and schizophrenic tissue: a quantitative cellular in situ hybridization study. Molec Brain Res 1995; 33: 333-342.
16. Seeman P, Guan H-C, Van Tol HHM. Dopamine D4 receptors elevated in schizophrenia. Nature 1993; 365: 441-445.
17. Pfeiffer A, Brandt V, Herz A. Psychotomimesis mediated by kappa opiate receptors. Science 1986; 233: 774-776.
18. Fawcett J, Scheftner W, Clark D, Hedeker D, Bibbons R, Coryell W. Clinical predictors of suicide in patients with major affective disorders: a controlled prospective study. Am J Psychiat 1987; 144: 35-40.
19. Le Moine C, Normand E, Bloch B. Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. Proc Natl Acad Sci USA 1991; 88: 4205-4209.
20. Bowden C, Theodorou AE, Cheetham SC, Lowther S, Katona CLE, Crompton MR et al. Dopamine D-1 and D-2 receptor binding sites in brain samples from depressed suicides and controls. Brain Res 1997; 752: 227-233.
21. Gabilondo AM, Meana JJ, Garcia-Sevilla JA. Increased density of μ-opioid receptors in the postmortem brain of suicide victims. Brain Res 1995; 682: 245-250.
22. Lord JAH, Waterfield AA, Hughes J, Kosterlitz HW. Endogenous opioid peptides: multiple agonists and receptors. Nature 1977; 267: 495-499.
23. Chavkin C, James IF, Goldstein A. Dynorphin is a specific endogenous ligand for the κ-opioid receptor. Science 1982; 215: 413-415.
24. Åsberg M, Träskman L, Thorén P. 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor? Arch Gen Psychiat 1976; 33: 1193-1197.
25. Stanley M, Virgilio J, Gershon S. Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 1982; 216: 1337-1339.
26. 2 and β-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiat 1900; 47: 1038-1047.
27. Young III WS, Bonner TI, Brann MR. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc Natl Acad Sci USA 1986; 83: 9827-9831.
28. Morris BJ, Reimer S, Höllt V, Herz A. Regulation of striatal prodynorphin mRNA levels by the raphe-striatal pathway. Molec Brain Res 1988; 4: 15-22.
29. Smiley PL, Johnson M, Bush L, Gibb JW, Hanson CR. Effects of cocaine on extrapyramidal and limbic dynorphin systems. J Pharmac Exper Ther 1990; 253: 938-943.